Sodium Chloride → HCID 18187489, 화합물
반응식
C(O)(C(F)(F)F)=O.C(OC([N:15]1[CH2:20][CH2:19][CH:18]([CH2:21][CH2:22][C:23]([F:31])([F:30])[C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[CH2:17][CH2:16]1)=O)(C)(C)C.C([O-])(O)=O.[Na+].[OH-].[Na+].[Na+].[Cl-]>C(Cl)Cl.O.CCOCC>[F:31][C:23]([F:30])([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)[CH2:22][CH2:21][CH:18]1[CH2:17][CH2:16][NH:15][CH2:20][CH2:19]1참가 물질
실험 절차
TFA (2.5 mL, 3.7 g, 32 mmol) was added dropwise to a solution of 1-(t-butoxycarbonyl)-4-(3,3-difluoro-3-phenylpropyl)piperidine (42 mg, 0.12 mmol, from EXAMPLE 154, Step C) in CH2Cl2 (2.5 mL) at 0° C. After 80 min., the solution was transferred using a double-ended needle to a rapidly stirred solution of NaHCO3 (5.0 g, 60 mmol) in H2O (50 mL). Ether (50 mL) and 2.5 N NaOH (20 mL) were added, followed by solid NaCl to saturate the aqueous layer. The aqueous layer was separated and extracted with ether (50 mL). The organic layers were washed in succession with saturated aq. NaCl (20 mL), combined, dried (Na2SO4), decanted,and evaporated to give the title compound as 27 mg of colorless oil. 1H NMR (400 MHz, CD3OD) δ 7.51-7.40 (m, 5H), 2.98 (dm, J=12,22H), 2.53 (td, J=12, 3, 2H), 2.24-2.10 (m, 2H), 1.65 (bd, J=12, 2H), 1.42-1.26 (m, 3H), 1.06 (qd, J=12,4,2H); ESI-MS 240 (M+H); HPLC A: 2.25 min.
후처리
- concentrationto saturate the aqueous layer
- customThe aqueous layer was separated
- extractionextracted with ether (50 mL)
- washThe organic layers were washed in succession with saturated aq. NaCl (20 mL)
- dry with materialdried (Na2SO4)
- customevaporated
출처 및 근거
- ORD 기록
- ord-6f07b499fd6f43a6a48e53e2b0596e82
- 출처 데이터셋
- uspto-grants-2001_07
- 특허 번호
- US06265434B1
반응 노트
불러오는 중…